期刊文献+

产尿酸氧化酶基因工程菌的构建 被引量:6

Construction of gene engineering bacterium to produce urate oxidase
下载PDF
导出
摘要 目的将尿酸氧化酶基因克隆到保加利亚乳酸杆菌中,使之能产生尿酸氧化酶,为开发能够分解尿酸、对高尿酸血症有治疗作用的可食用基因工程菌奠定基础。方法根据genbank上已知的产朊假丝酵母菌尿酸氧化酶基因序列(Uricase,E12709),PCR扩增尿酸氧化酶基因片段,将其插入质粒pMG36e,构建成重组质粒pMG36e-U,电转化保加利亚乳酸杆菌,SDS-PAGE鉴定基因工程菌体裂解液中的尿酸氧化酶,测定尿酸氧化酶活性。结果从产朊假丝酵母基因组中PCR扩增到尿酸氧化酶基因,并构建成含有尿酸氧化酶基因的重组质粒pMG36e-U,重组质粒pMG36e-U电转化保加利亚乳酸杆菌成功构建了含尿酸氧化酶的基因工程乳酸杆菌。SDS-PAGE测定基因工程菌合成的尿酸氧化酶亚基分子量约为34 kD,在体外测定菌酶液活性可达0.33 U.mL-1。结论尿酸氧化酶基因克隆入保加利亚乳酸杆菌中,并具有酶分解能力。 Objective To clone urate oxidase gene into lactobacillus Bulgaria so as to produce urate oxidase, and to lay basis for the development of edible genetic engineering bacteria to treat hyperuricemia. Methods According to genbank's known candida utilis urate oxidase gene sequences (Uricase, E12709) in the genbank, PCR amplification of urate oxidase gene fragments was done and inserted into plasmid pMG36e to construct the recombinant plasmid pMG36e- U. Electrotransformation of lactobacillus Bulgaria, SDS-PAGE analysis of the urate oxidase in the genetic engineering cell lysate urate oxidase activity were done. Results Genome which suspended animation production yeast prion was amplified to uric acid oxidase gene by polymerase chain reaction (PCR), and its recombinant plasmid pMG36e-U con- structed. The pMG36e-U constructed genetically engineered lactobacillus which contained uric acid oxidase gene by electrotransformation of lactobacillus Bulgaria. The molecular weight of uric acid oxidase subunit was 34 kD by SDS- PAGE. The activity of bacteria enzyme was up to 0. 33 U·mL^-1 in vitro. Conclusion The uric acid oxidase gene which is cloned in lactobacillus Bulgaria has an ability of enzyme decomposition.
出处 《中南药学》 CAS 2009年第6期401-404,共4页 Central South Pharmacy
基金 国家自然科学基金资助项目(NO:30670974)
关键词 基因克隆 基因工程菌 尿酸氧化酶 乳酸杆菌 gene cloning genetic engineering bacteria urate oxidase lactic acid bacteria
  • 相关文献

参考文献11

  • 1吴欣,陶冶.高尿酸血症与肾脏疾病[J].现代临床医学,2007,33(1):68-71. 被引量:11
  • 2Morisaki T, Morisaki H. Urate production and regulation and regulation and regulation [J]. Nippon Rinsho, 2008, 66 (4): 653-658.
  • 3Safra N, Ling GV, Schaible R, et al. Exclusion of urate oxidase as a candidate gene for hyperurieosuria in the Dalmatian dog using an interbreed backeross [J]. Hered. 2005, 96 (7): 750-754.
  • 4施桂英.痛风——降尿酸治疗的新策略[J].中华风湿病学杂志,2007,11(3):129-131. 被引量:21
  • 5刘广桢,陈建华,王旻.尿酸酶产生菌的筛选、基因克隆及表达[J].中国药科大学学报,2005,36(5):464-467. 被引量:10
  • 6Schumacher HR, Chen LX. Newer therapeutic approaches: gout [J]. Rheum Dis Clin N Am. 2006, 32 (2): 235-244.
  • 7Guarner F, Malagelada JR. Gut Flora in health and disease [J]. Lancet, 2003, 361 (9356): 512-519.
  • 8Fabian E, Elmadfa I. The effect of daily consumption of probiotic and conventional yoghurt on oxidant and anti-oxidant parameters in plasma of young healthy women[J].Int J Vitam Nutr Res, 2007, 77 (2): 79-88.
  • 9Paturi G, Phillips M, Jones M, et al . Immune enhancing effects of Lactobacillus acidophilus LAFT IL10 and Lactobacillus paracasei LAFT IL26 in mice [J]. Int J Food Microbiol, 2007, 115 (1): 115-118.
  • 10Koyama Y, Ichikawa T, Nakano E, et al. Cloning, sequencing and expression in Escherichia coli of uriease gene from Candida utilis [J]. Biochem, 1996, 120 (5), 969-973.

二级参考文献46

  • 1姜林娣,Peter Tugwell.痛风和高尿酸血症处理中的循证医学观点[J].中华风湿病学杂志,2005,9(2):120-122. 被引量:16
  • 2陈香美,吴镝.尿酸性肾病[J].中华内科杂志,2005,44(3):231-233. 被引量:59
  • 3施桂英.走出痛风性关节炎诊断和治疗的误区[J].中华全科医师杂志,2006,5(9):519-522. 被引量:51
  • 4Ronco C,Bellomo R,Inguaggiato P,et al. Rasburicase therapy in acute hyperuricemic renal dysfunction[J]. Contrib Nephrol,2004,144:158 -165.
  • 5Bomalaski JS,Clark MA. Serum uric acid-lowering therapies:where are we heading in management of hyperuricemia and the potential role of uricase[J]. Curr Rheumatol Rep,2004,6(3):240 -247.
  • 6Lee AC,Li CH,So KT,et al. Treatment of impending tumor lysis with single-dose rasburicase[J]. Ann Pharmacother,2003,37(11):1 614 -1 617.
  • 7Hummel M,Buchheidt D,Reiter S,et al. Successful treatment of hyperuricemia with low doses of recombinant urate oxidase in four patients with hematologic malignancy and tumor lysis syndrome[J]. Leukemia,2003,17(12):2 542 -2 544.
  • 8Bosly A,Sonet A,Pinkerton CR,et al. Rasburicase (recombinant urate oxidase) for the management of hyperuricemia in patients with cancer:report of an international compassionate use study[J]. Cancer,2003,98(5):1 048 -1 054.
  • 9Fraisse L,Bonnet MC,Agut C,et al. A colorimetric 96-well microtiter plate assay for the determination of urate oxidase activity and its kinetic parameters[J]. Anal Biochem,2002,309(2):173 -179.
  • 10Liu J,Li GX,Liu H,et al. Purification and properties of uricase from Candida sp. and its application in uric acid analysis in serum[J]. Ann NY Acad Sci,1995,750:477 -481.

共引文献38

同被引文献51

引证文献6

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部